{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T11:52:28Z","timestamp":1774353148507,"version":"3.50.1"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1097\/rlu.0b013e318286bd84","type":"journal-article","created":{"date-parts":[[2013,3,12]],"date-time":"2013-03-12T12:31:20Z","timestamp":1363091480000},"page":"354-358","source":"Crossref","is-referenced-by-count":12,"title":["Combined Imaging With 18F-FDG-PET\/CT and 111In-Labeled Octreotide SPECT for Evaluation of Thymic Epithelial Tumors"],"prefix":"10.1097","volume":"38","author":[{"given":"Serena","family":"De Luca","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa","family":"Fonti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovannella","family":"Palmieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piera","family":"Federico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppina","family":"Del Prete","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Pacelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonardo","family":"Pace","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabino","family":"De Placido","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Salvatore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvana","family":"Del Vecchio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-9-20210204","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.lungcan.2008.01.014","article-title":"A review of thymic tumors.","volume":"60","author":"Srirajaskanthan","year":"2008","journal-title":"Lung Cancer"},{"issue":"suppl 4","key":"R2-9-20210204","doi-asserted-by":"crossref","first-page":"S296","DOI":"10.1097\/JTO.0b013e3181f209ca","article-title":"Imaging thymoma.","volume":"5","author":"Marom","year":"2010","journal-title":"J Thorac Oncol"},{"key":"R3-9-20210204","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1007\/BF01791148","article-title":"Use of fluorine-18 fluorodeoxyglucose positron emission tomography in the detection of thymoma: a preliminary report.","volume":"22","author":"Liu","year":"1995","journal-title":"Eur J Nucl Med"},{"key":"R4-9-20210204","first-page":"1595","article-title":"Differential diagnosis of thymic tumors using a combination of 11C-methionine PET and FDG PET.","volume":"40","author":"Sasaki","year":"1999","journal-title":"J Nucl Med"},{"key":"R5-9-20210204","first-page":"1628","article-title":"F-18-FDG PETCT of thymic epithelial tumors: usefulness for distinguishing and staging tumor subgroups.","volume":"47","author":"Sung","year":"2006","journal-title":"J Nucl Med"},{"key":"R6-9-20210204","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.lungcan.2008.01.003","article-title":"Utility of F-18DG-PET for differentiating the grade of malignancy in thymic epithelial tumors.","volume":"61","author":"Endo","year":"2008","journal-title":"Lung Cancer"},{"key":"R7-9-20210204","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.lungcan.2011.02.018","article-title":"Usefulness of 18-F FDG PETCT in the pre-treatment evaluation of thymic epithelial neoplasms.","volume":"74","author":"Terzi","year":"2011","journal-title":"Lung Cancer"},{"key":"R8-9-20210204","doi-asserted-by":"crossref","first-page":"3746","DOI":"10.1200\/JCO.2009.27.4662","article-title":"Biologic correlation of 2-F-18-fluoro-2-deoxy-D-glucose uptake on positron emission tomography in thymic epithelial tumors.","volume":"28","author":"Kaira","year":"2010","journal-title":"J Clin Oncol"},{"key":"R9-9-20210204","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ejrad.2010.08.010","article-title":"F-18DG PET for grading malignancy in thymic epithelial tumors: significant differences in F-18DG uptake and expression of glucose transporter-1 and hexokinase II between low and high-risk tumors: preliminary study.","volume":"81","author":"Nakajo","year":"2012","journal-title":"Eur J Radiol"},{"issue":"suppl 4","key":"R10-9-20210204","doi-asserted-by":"crossref","first-page":"S304","DOI":"10.1097\/JTO.0b013e3181f20c05","article-title":"Staging system of thymoma.","volume":"5","author":"Masaoka","year":"2010","journal-title":"J Thorac Oncol"},{"key":"R11-9-20210204","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1007\/s00259-010-1473-6","article-title":"111In-pentetreotide scintigraphy: procedure guidelines for tumour imaging.","volume":"37","author":"Bombardieri","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R12-9-20210204","first-page":"634","article-title":"In vivo detection of malignant thymic masses by indium-111-DTPA-D-Phe1-octreotide scintigraphy.","volume":"39","author":"Lastoria","year":"1998","journal-title":"J Nucl Med"},{"key":"R13-9-20210204","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0344-0338(99)80008-9","article-title":"Somatostatin receptor scintigraphy in thymoma imaging method and clinical application.","volume":"195","author":"Marienhagen","year":"1999","journal-title":"Pathol Res Pract"},{"key":"R14-9-20210204","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/00003072-199901000-00006","article-title":"Somatostatin receptor scintigraphy and somatostatin therapy in the evaluation and treatment of malignant thymoma.","volume":"24","author":"Lin","year":"1999","journal-title":"Clin Nucl Med"},{"key":"R15-9-20210204","doi-asserted-by":"crossref","first-page":"875","DOI":"10.2967\/jnumed.109.066134","article-title":"The role of 68Ga-DOTATATE PET in patients with neuroendocrine tumors and negative or equivocal findings on In-111-DTPA-octreotide scintigraphy.","volume":"51","author":"Srirajaskanthan","year":"2010","journal-title":"J Nucl Med"},{"key":"R16-9-20210204","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s00259-008-0944-5","article-title":"Correlation of immunohistopathological expression of somatostatin receptor 2 with standardised uptake values in 68Ga-DOTATOC PETCT.","volume":"36","author":"Miederer","year":"2009","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R17-9-20210204","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1053\/j.seminoncol.2010.10.015","article-title":"Molecular imaging of neuroendocrine tumors.","volume":"37","author":"Carrasquillo","year":"2010","journal-title":"Semin Oncol"},{"key":"R18-9-20210204","doi-asserted-by":"crossref","first-page":"E1056","DOI":"10.1152\/ajpendo.00205.2001","article-title":"Quantitative and functional expression of somatostatin receptor subtypes in human thymocytes.","volume":"283","author":"Ferone","year":"2002","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"R19-9-20210204","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1056\/NEJM199701233360405","article-title":"Successful treatment of a patient with a thymoma and pure red-cell aplasia with octreotide and prednisone.","volume":"336","author":"Palmieri","year":"1997","journal-title":"N Engl J Med"},{"key":"R20-9-20210204","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1200\/JCO.2004.02.047","article-title":"An Eastern Cooperative Oncology Group Phase II Trial. Octreotide alone or with prednisone in patients with advanced thymoma and thymic carcinoma: an Eastern Cooperative Oncology Group Phase II Trial.","volume":"22","author":"Loehrer","year":"2004","journal-title":"J Clin Oncol"},{"key":"R21-9-20210204","doi-asserted-by":"crossref","first-page":"4820","DOI":"10.1200\/JCO.2011.36.0487","article-title":"Thymic malignancies: from clinical management to targeted therapies.","volume":"29","author":"Kelly","year":"2011","journal-title":"J Clin Oncol"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0b013e318286bd84","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T19:29:28Z","timestamp":1621884568000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003072-201305000-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":21,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0b013e318286bd84","relation":{},"ISSN":["0363-9762"],"issn-type":[{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]}}}